Clinical Trial Update: Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen in Acute Myeloid Leukemia: Study Protocol for a Randomized Controlled Trial [Phase 3]

View source ↗

Summary

Study protocol for a randomized Phase 3 trial evaluating a dual growth factor (rhTPO + G-CSF) with chemotherapy in acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Huihan Wang | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: UNKNOWN